Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Coronavirus evolution mapping will unlock treatment options

Over 200 recurrent genetic mutations in the coronavirus have been identified by a UCL-led research team offering clues to direct drugs and vaccine targets.

Over 200 recurrent genetic mutations in the coronavirus have been identified by a UCL-led research team offering clues to direct drugs and vaccine targets. The team analysed virus genomes from over 7,500 people infected with Covid-19 and found that a large proportion of the global genetic diversity of SARS-CoV-2 is found in all hardest-hit countries, suggesting extensive global transmission from early on in the epidemic and the absence of single ‘Patient Zeroes’ in most countries. The findings, published in Infection, Genetics and Evolution, also further establish that the virus only emerged recently in late 2019, before quickly spreading across the globe. A vaccine might

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy